The Revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals
- 1 January 1999
- journal article
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 15 (5), 459-468
- https://doi.org/10.2165/00019053-199915050-00004
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Are We Ready to Use Cost-Effectiveness Analysis in Health Care Decision-Making?Medical Care, 1998
- A Radical Rupture in the Paradigm of Modern Medicine: Conflicts of Interest, Fiduciary Obligations, and the Scientific IdealJournal of Medicine and Philosophy, 1998
- Using pharmacoeconomic analysis to make drug insurance coverage decisions.PharmacoEconomics, 1998
- The Danish Approach to Standards For Economic Evaluation MethodologiesPharmacoEconomics, 1997
- Data sources for pharmacoeconomic and health services research.American Journal of Health-System Pharmacy, 1997
- Managed care pharmacy, socioeconomic assessments and drug adoption decisionsSocial Science & Medicine, 1997
- Providing cost-effective therapy using pharmacoeconomic evaluations: the public sector approachClinical Therapeutics, 1997
- Guidelines for Pharmacoeconomic StudiesPharmacoEconomics, 1997
- Confidence intervals for cost-effectiveness ratios: An application of Fieller's theoremHealth Economics, 1996
- The Emerging Government Requirement for Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1994